The present disclosure pertains to medical devices, and methods for manufacturing and using medical devices. More particularly, the disclosure is directed to a medical device that is adapted for multiple deployments and recaptures of an implant.
A wide variety of medical devices have been developed for medical use, for example, for use in accessing body cavities and interacting with fluids and structures in body cavities. Some of these devices may include guidewires, catheters, pumps, motors, controllers, filters, grinders, needles, valves, and delivery devices and/or systems used for delivering such devices. These devices are manufactured by any one of a variety of different manufacturing methods and may be used according to any one of a variety of methods. Of the known medical devices and methods, each has certain advantages and disadvantages.
This disclosure provides design, material, manufacturing method, and use alternatives for medical devices. As an example, a medical device includes an elongate shaft and a rigid member that is secured relative to the elongate shaft. The elongate shaft includes an inner polymeric liner that defines a lumen extending therethrough, an outer polymeric sheath, and a reinforcing braid that extends within the outer polymeric sheath. The reinforcing braid includes a plurality of wire ends that extend beyond a distal edge of the rigid member.
Alternatively or additionally, a distal region of the elongate shaft may be adapted for delivering and/or recapturing an implant, and the rigid member is disposed within the distal region of the elongate shaft.
Alternatively or additionally, the plurality of wire ends may extend distally from the distal edge of the rigid member.
Alternatively or additionally, the plurality of wire ends may also extend radially outwardly from the distal edge of the rigid member.
Alternatively or additionally, the plurality of wire ends may form ramps that are adapted to keep the implant, when recaptured, from contacting the distal edge of the rigid member, even if the inner polymeric liner is damaged.
Alternatively or additionally, the inner polymeric liner being damaged may include the inner polymeric liner delaminating and exposing the distal edge of the rigid member to an interior of the lumen extending through the inner polymeric liner.
Alternatively or additionally, the plurality of wire ends may extend radially outwardly from the distal edge of the rigid member.
Alternatively or additionally, the plurality of wire ends that extend radially outwardly from the distal edge of the rigid member may form ramps that are adapted to keep the implant, when recaptured, from contacting the distal edge of the rigid member, even if the inner polymeric liner is damaged.
Alternatively or additionally, the rigid member may include a metallic member.
Alternatively or additionally, the rigid member may include a polymeric member.
Alternatively or additionally, the rigid member may include a section of hypotube.
Alternatively or additionally, the rigid member may include a marker band.
As another example, a device is adapted for delivering and/or recapturing an implant. The device includes an elongate shaft and a marker band that is secured relative to the elongate shaft. The elongate shaft includes an inner polymeric liner defining a lumen extending therethrough, an outer polymeric sheath, and a reinforcing braid extending within the outer polymeric sheath. The reinforcing braid includes a plurality of wire ends that extend beyond a distal edge of the marker band, the plurality of wire ends adapted to keep the implant, when retrieved, from contacting the distal edge of the marker band, even if the inner polymeric liner is damaged.
Alternatively or additionally, the plurality of wire ends may extend distally from the distal edge of the marker band.
Alternatively or additionally, the plurality of wire ends may also extend radially outwardly from the distal edge of the marker band.
Alternatively or additionally, the plurality of wire ends may extend radially outwardly and not distally from the distal edge of the marker band.
As another example, a medical device includes an elongate shaft having a distal region. The distal region of the elongate shaft includes an inner polymeric liner defining a lumen adapted to accommodate the implant therein, an outer polymeric sheath, a reinforcing braid extending within the outer polymeric sheath, and a marker band disposed between the inner polymeric layer and the outer polymeric sheath. The reinforcing braid includes a plurality of wire ends that extend beyond the marker band, the plurality of wire ends adapted to keep the implant, when recaptured, from contacting the marker band, even if the inner polymeric liner is damaged.
Alternatively or additionally, the plurality of wire ends may extend distally from the marker band.
Alternatively or additionally, the plurality of wire ends may also extend radially outwardly from the marker band.
Alternatively or additionally, the plurality of wire ends may extend radially outwardly and not distally from the marker band.
The above summary of some embodiments is not intended to describe each disclosed embodiment or every implementation of the present disclosure. The Figures, and Detailed Description, which follow, more particularly exemplify these embodiments.
The invention may be more completely understood in consideration of the following detailed description of various embodiments of the invention in connection with the accompanying drawings, in which:
While the disclosure is amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit the disclosure to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the disclosure.
For the following defined terms, these definitions shall be applied, unless a different definition is given in the claims or elsewhere in this specification.
All numeric values are herein assumed to be modified by the term “about,” whether or not explicitly indicated. The term “about” generally refers to a range of numbers that one of skill in the art would consider equivalent to the recited value (i.e., having the same function or result). In many instances, the terms “about” may include numbers that are rounded to the nearest significant figure.
The recitation of numerical ranges by endpoints includes all numbers within that range (e.g. 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5).
As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the content clearly dictates otherwise. As used in this specification and the appended claims, the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.
The following detailed description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention.
In some cases, the proximal region 14 may include a proximal hub 18, although this is not required in all cases. In some instances, the proximal region 14 may include additional components (not shown), including but not limited to additional hubs or fluid ports and actuatable members useable for deploying and/or retrieving an implant such as an implant 20. A portion of the implant 20 still within the distal region 16 of the elongate shaft 12 is shown in phantom, while a portion of the implant 20 that has moved distally out of the distal region 16 of the elongate shaft 12 is shown in solid line.
The implant 20 may generically represent any of a variety of different implantable medical devices that can be delivered within a device such as the medical device 10. For example, the implant 20 may represent a stent, a coil, a clip, a transcatheter valve implant such as an aortic valve implant, a mitral valve implant, a tricuspid valve implant, a filter, a snare, a balloon, and other medical devices. In some instances, the implant 20 may be a left atrial appendage (LAA) implant such as the WATCHMAN™ commercially available from Boston Scientific.
A deployment member 22 extends through the elongate shaft 12 and includes an engagement member 24 at a distal end thereof. A portion of the deployment member 22 extending through the elongate shaft 12 is shown in phantom, while a portion of deployment member 22 extending proximally from the elongate shaft 12 is shown in solid line. The engagement member 24 may be considered as being adapted to releasably engage the implant 20 and to continue engaging the implant 20 through one or more deployments. If an initial deployment does not yield an appropriate location or orientation of the implant 20, the implant 20 may be recaptured, repositioned and redeployed, particularly when the engagement member 24 retains a connection with the implant 20.
Once the implant 20 has been determined to be disposed in an appropriate position and orientation, for example, the engagement member 24 may be adapted to disengage the implant 20 and thus release the implant 20. In some cases, the implant 20 may never be released from the engagement member 24, and may remain attached to the engagement member 24 during use of the implant 20. After temporary use of the implant 20, the implant 20 as well as the medical device 10 may be removed from the patient.
In some cases, repeated deployment and recapture of the implant 20, particularly while attempting to optimize placement of the implant 20, can stress components within the distal region 16 of the elongate shaft 12.
The distal region 26 includes a rigid member 34 that in some instances represents a marker band in order to provide visualization of the distal region 26 during use of the medical device 10. In some cases, as shown, the rigid member 34 is disposed between the inner polymeric liner 28 and the outer polymeric sheath 32. The rigid member 34 may be metallic or polymeric. In cases in which the rigid member 34 serves as a marker band, the rigid member 34 may be formed of a material such as tungsten, a platinum/iridium alloy, tantalum and tantalum alloys, other metals and alloys having radiopaque properties, or stainless steel.
The outer polymeric sheath 32 includes a braid 36.
The braid 36 extends distally beyond a distal edge 38 of the rigid member 34. The braid 36 includes a number of wire ends 40, individually labeled here as 40a, 40b, 40c and 40d. This is merely illustrative, as the braid 36 may have a greater number of wire ends 40 extending distally beyond the distal edge 38 of the rigid member 34.
In some cases, as shown for example in
As a result, and as shown in
Accordingly, by constructing the distal region 26 in this fashion, with the wire ends 40 extending distally beyond the distal edge 38 of the rigid member 34, it is possible to provide the implant 20 with protection against possible damage that could otherwise be caused by delamination or other damage to the inner polymeric liner 28 that exposes the distal edge 38 of the rigid member 34. The wire ends 40 are adapted to extend tangent to the inner diameter of the rigid member 34, rather than curving along the inner polymeric liner 28.
The outer polymeric sheath 52 includes a braid 56.
The braid 56 extends distally beyond a distal edge 58 of the rigid member 54. The braid 56 includes a number of wire ends 60, individually labeled here as 60a, 60b, 60c, 60d, 60e and 60f. This is merely illustrative, as the braid 56 may have a greater number of wire ends 60 extending distally beyond the distal edge 58 of the rigid member 54.
In some cases, as shown for example in
As a result, and as shown in
Accordingly, by constructing the distal region 46 in this fashion, with the wire ends 60 extending distally beyond the distal edge 58 of the rigid member 54, it is possible to provide the implant 20 with protection against possible damage that could otherwise be caused by delamination or other damage to the inner polymeric liner 48 that exposes the distal edge 58 of the rigid member 54.
The braid, which is not visible in this view, may have any of a variety of different braiding patterns, for example, and may be formed of a variety of metallic or even polymeric materials. The braid may have any number of braid wires that are woven together to form the braid. The braid terminates distally with a number of wire ends 72, individually labeled as 72a, 72b, 72c and 72d. This is merely illustrative, as the braid may have a greater number of wire ends 72 extending distally beyond the distal edge 70 of the rigid member 68.
It will be appreciated that the arrangement of the wire ends 72 is similar to that of the wire ends 40 shown in
The braid, which is not visible in this view, may have any of a variety of different braiding patterns, for example, and may be formed of a variety of metallic or even polymeric materials. The braid may have any number of braid wires that are woven together to form the braid. The braid terminates distally with a number of wire ends 92, individually labeled as 92a, 92b, 92c, 92d, 92e and 92f. This is merely illustrative, as the braid may have a greater number of wire ends 92 extending distally beyond the distal edge 90 of the rigid member 88.
It will be appreciated that the arrangement of the wire ends 92 is similar to that of the wire ends 60 shown in
The devices described herein may be formed of a variety of different metallic and polymeric materials. Suitable metallic materials can include stainless steel and Nitinol. Additional examples of suitable polymers include but are not limited to polytetrafluoroethylene (PTFE), ethylene tetrafluoroethylene (ETFE), fluorinated ethylene propylene (FEP), polyoxymethylene (POM, for example, DELRIN® available from DuPont), polyether block ester, polyurethane (for example, Polyurethane 85A), polypropylene (PP), polyvinylchloride (PVC), polyether-ester (for example, ARNITEL® available from DSM Engineering Plastics), ether or ester based copolymers (for example, butylene/poly(alkylene ether) phthalate and/or other polyester elastomers such as HYTREL® available from DuPont), polyamide (for example, DURETHAN® available from Bayer or CRISTAMID® available from Elf Atochem), elastomeric polyamides, block polyamide/ethers, polyether block amide (PEBA, for example available under the trade name PEBAX®), ethylene vinyl acetate copolymers (EVA), silicones, polyethylene (PE), Marlex® high-density polyethylene, Marlex® low-density polyethylene, linear low density polyethylene (for example REXELL®), polyester, polybutylene terephthalate (PBT), polyethylene terephthalate (PET), polytrimethylene terephthalate, polyethylene naphthalate (PEN), polyetheretherketone (PEEK), polyimide (PI), polyetherimide (PEI), polyphenylene sulfide (PPS), polyphenylene oxide (PPO), poly paraphenylene terephthalamide (for example, KEVLAR®), polysulfone, nylon, nylon-12 (such as GRILAMID® available from EMS American Grilon), perfluoro(propyl vinyl ether) (PFA), ethylene vinyl alcohol, polyolefin, polystyrene, epoxy, polyvinylidene chloride (PVdC), poly(styrene-b-isobutylene-b-styrene) (for example, SIBS and/or SIBS 50A), polycarbonates, ionomers, biocompatible polymers, other suitable materials, or mixtures, combinations, copolymers thereof, polymer/metal composites, and the like. Additional materials include liquid crystal polymers.
It should be understood that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of steps without exceeding the scope of the disclosure. This may include, to the extent that it is appropriate, the use of any of the features of one example embodiment being used in other embodiments. The invention’s scope is, of course, defined in the language in which the appended claims are expressed.
This application claims the benefit of priority of U.S. Provisional Application No. 63/292,541 filed Dec. 22, 2021, the entire disclosure of which is hereby incorporated by reference.
Number | Date | Country | |
---|---|---|---|
63292541 | Dec 2021 | US |